A scoping review of health economic evaluation in the World Health Organization Eastern Mediterranean region

References

• Health systems financing: the path to universal coverage. World Health Organization; 2010.
   Google Scholar
• 2015 global survey on health technology assessment by national authorities. World Health Organization; 2015.
   Google Scholar
• Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296(13):716–721.
   PubMed Web of Science ®Google Scholar
• Frick K, Neissen L, Bridges J, et al. Usefulness of economic evaluation data in systematic reviews of evidence. 2012.
   Google Scholar
• Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford university press; 2015.
   Google Scholar
• Drummond MF, Schwartz JS, Jönsson B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24(3):244–258.
   PubMed Web of Science ®Google Scholar
• Organization WH. 2015 global survey on health technology assessment by national authorities. 2015.
   Google Scholar
• WHO regional office for the Eastern Mediterranean World Health Organization; [cited 2020 Sep 17]. Available from: http://www.emro.who.int/countries.html
   Google Scholar
• Facey K, Topfer L-A, Chan L Health technology assessment (HTA) glossary. INAHTA–International Network of Agencies for Health Technology Assessment. 2006.
   Google Scholar
• Mokdad AH, Forouzanfar MH, Daoud F, et al. Health in times of uncertainty in the Eastern Mediterranean region, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet Glob Health. 2016;4(10):e704–e713.
   PubMed Web of Science ®Google Scholar
• Pharmaceuticals and Healthcare Outlook for 2017:Middle East & North Africa; 2016 cited.
   Google Scholar
• Mandil A, Chaaya M, Saab D. Health status, epidemiological profile and prospects: Eastern Mediterranean region. Int J Epidemiol. 2013;42(2):616–626.
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Jaber S, Aziz MIA, et al. The state of health in the Arab world, 1990–2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014;383(9914):309–320.
   PubMed Web of Science ®Google Scholar
• Fasseeh A, Karam R, Jameleddine M, et al. Implementation of health technology assessment in the Middle East and North Africa: comparison between the current and preferred status. Front Pharmacol. 2020;11:15.
   PubMed Web of Science ®Google Scholar
• Peters M, Godfrey C, McInerney P, et al. The Joanna Briggs Institute reviewers’ manual 2015: methodology for JBI scoping reviews; 2015.
   Google Scholar
• Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Internal Med. 2018;169(7):467–473.
   PubMed Web of Science ®Google Scholar
• Shemilt I, Mugford M, Byford S, et al. 15 Incorporating economics evidence. In: Julian PT Higgins, Sally Green, editors. Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell (A John Wiley & Sons, Ltd., Publication); 2008. p. 449.
   Google Scholar
• Organization WH. Strengthening health financing systems in the Eastern Mediterranean Region towards universal health coverage: health financing atlas 2018; 2019.
   Google Scholar
• Boncz I, Kaló Z, Ibrahim MIBM, et al. Further steps in the development of pharmacoeconomics, outcomes research, and health technology assessment in Central and Eastern Europe, Western Asia, and Africa. Value Health Reg Issues. 2013;2(2):169–170.
   PubMedGoogle Scholar
• Pitt C, Goodman C, Hanson K. Economic evaluation in global perspective: a bibliometric analysis of the recent literature. Health Econ. 2016;25:9–28.
   PubMed Web of Science ®Google Scholar
• Pandey P, Pandey RD, Shah V. Evaluation of quality of pharmacoeconomic studies in Asia-Pacific region and identification of influencing variables. Value Health Reg Issues. 2018;15:70–75.
   PubMedGoogle Scholar
• Panzer AD, Emerson JG, D’Cruz B, et al. Growth and capacity for cost-effectiveness analysis in Africa. Health Econ. 2020;29(8):945–954. PubMed PMID: 32412153; eng.
   PubMed Web of Science ®Google Scholar
• Alefan Q, Rascati K. Pharmacoeconomic studies in World Health Organization Eastern Mediterranean countries: reporting completeness. Int J Technol Assess Health Care. 2017;33(2):215.
   PubMed Web of Science ®Google Scholar
• Rezapour A, Moradpour A, Panahi S, et al. Health economic evaluation in Iran (1998–2017), a bibliometrics analysis. Int J Pharm Phytopharm Res. 2020;10(4):95–102.
   Web of Science ®Google Scholar
• Eljilany I, El-Dahiyat F, Curley LE, et al., Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries. Expert Rev Pharmacoecon Outcomes. 2018;18(4):403–414.
   PubMed Web of Science ®Google Scholar
• Greenberg D, Rosen AB, Wacht O, et al. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976–2006. Med Decis Making. 2010;30(3):320–327.
   PubMed Web of Science ®Google Scholar
• Al-Aqeel SA. State of health economic evaluation research in Saudi Arabia: a review. Clinico Econ Outcomes Res. 2012;4:177.
   PubMedGoogle Scholar
• Haghparast-Bidgoli H, Kiadaliri AA, Skordis-Worrall J. Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literature. Cost Eff Resour Allocation. 2014;12(1):15.
   PubMed Web of Science ®Google Scholar
• Farid S, Elmahdawy M, Baines D. A systematic review on the extent and quality of pharmacoeconomic publications in Egypt. Clin Drug Invest. 2019;39(2):157–168.
   PubMed Web of Science ®Google Scholar
• Walker D, Fox‐Rushby JA. Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature. Health Econ. 2000;9(8):681–698.
   PubMed Web of Science ®Google Scholar
• Doaee S, Oliyaeemanesh A, Nejati M, et al. Establishment of health technology assessment in Iran [Article]. J Family Reprod Health. 2012;6(2):73–78. English.
   Google Scholar
• Doaee S, Olyaeemanesh A, Emami S, et al. Development and implementation of health technology assessment: a policy study. Iran J Public Health. 2013;07/18(42):50–54.
   Google Scholar
• Elsisi GH, Kaló Z, Eldessouki R, et al. Recommendations for reporting pharmacoeconomic evaluations in Egypt. Value Health Reg Issues. 2013;2(2):319–327.
   PubMedGoogle Scholar
• Alefan Q, AlImam S, Mukattash T, et al. Pharmacoeconomics education in WHO Eastern Mediterranean region. Curr Pharm Teach Learn. 2015;7(6):819–825.
   Web of Science ®Google Scholar
• Arab-Zozani M, Majdzadeh R, Sarbakhsh P, et al. The attitude of health technology assessment students to their field of study and future career in Iran. Int J Epidemiol Res. 2017;4(3):227–231.
   Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Int J Technol Assess Health Care. 2013;29(2):117–122.
   PubMed Web of Science ®Google Scholar